 |
| Patient safety is of utmost importance
to Genus Pharmaceuticals. All reports of potential safety
issues associated with Genus products are taken extremely
seriously. |
| |
What is Pharmacovigilance
and why is it needed?
Pharmacovigilance is defined as "The science and
activities relating to the detection, assessment, understanding
and prevention of the adverse effects or any other drug related
problems." |
| |
| While medicines have led to major
improvement in the treatment and control of disease, all may
cause side effects in some people. |
| |
Company Responsibilities
Pharmaceutical companies are responsible for the continued
monitoring of the safety of their products. To manage these
responsibilities companies must fulfil a number of obligations
including the collection and investigation of information
relating to side effects of their medicines, and reporting
adverse events to the regulatory authorities within strict
timelines. |
| |
| Information from spontaneous reports
provided by health professionals and patients is of great
value during the regular reviews of the safety profile of
Genus products, and enables the provision of a better service
to health professionals and patients enquiring about side-effects
and toxicity. |
| |
If you, or someone you know, has
experienced an adverse event when using a Genus product, please
call:
01635 568 400 |
| |
To report an adverse event when using
any medicine, please complete a Yellow Card Report at:
The
Medicines and Healthcare products Regulatory Agency (MHRA) |
| |
| Alternatively, Yellow Card Report
Forms can be found at your local pharmacy or doctor's practice.
|
